First-trimester multi-modal cell-free DNA analysis for prediction of preterm and term preeclampsia
Rebecca Ertl, Argyro Syngelaki, Olga Frank, Lukas Lüftinger, Eva Lukáčová, Casper Lumby, Adrian Stütz, Stephan Beisken, Andreas E. Posch, Kypros H. Nicolaides · 2026
Read First-trimester multi-modal cell-free DNA analysis for prediction of preterm and term preeclampsia by Rebecca Ertl, Argyro Syngelaki, Olga Frank, Lukas Lüftinger, Eva Lukáčová, Casper Lumby, Adrian Stütz, Stephan Beisken, Andreas E. Posch, Kypros H. Nicolaides (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13319718.txt.
Description
Rebecca Ertl and colleagues report, in 2026, a first-trimester blood test approach for predicting preeclampsia, a dangerous pregnancy condition involving high blood pressure. Current screening predicts early disease well but performs poorly for disease arising at term, and it depends on ultrasound and blood measurements that limit scale.
The study used cell-free DNA already collected during routine prenatal testing in 125 pregnancies, sampled at eleven to fourteen weeks. Sequencing that reads fragment patterns and chemical marks allowed tissue-resolved analysis. Separate learning models were built for early and term disease. Both models discriminated cases well, beating the standard score clearly for term disease. A simulation in a large population explored predictive values. The authors propose one molecular test for the full spectrum.
Catalog record
| CREATOR | Rebecca Ertl, Argyro Syngelaki, Olga Frank, Lukas Lüftinger, Eva Lukáčová, Casper Lumby, Adrian Stütz, Stephan Beisken, Andreas E. Posch, Kypros H. Nicolaides |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |